nebulized glutathione lyme Assessment of lipid mediators in the urine of patients with disease, tick-borne encephalitis and human granulocytic anaplasmosis Utilizing Glutathione for Lyme Disease,
Description
Bayet-Robert et al., 2010), lung (Alexandrow et al., 2012), colorectal (Howells et al., 2019), pancreatic (Kanai et al., 2011
doi: 10.2174/138920312802430554
Clinical pharmacology of exogenously administered alkaline phosphatase
Systemic effects are rare in user reports but are not well characterized in published trials
